What is Corneal Transplant Market?
The cornea copes fine with minor injuries or abrasions. If the sensitive cornea is scratched, healthy cells slide over quickly and patch the injury before infection occurs and vision is affected. If the scratch penetrates the cornea more deeply, however, the healing process will take longer, sometimes leading to greater pain, blurred vision, tearing, redness, and extreme sensitivity to light. These symptoms require professional treatment. Deeper scratches also can cause corneal scarring, leading to a haze on the cornea that may greatly impair vision. during this case, a corneal graft could also be needed.
The market study is being classified by Type (Penetrating Keratoplasty, Endothelial Keratoplasty, Descemet Stripping Automated Endothelial Keratoplasty, Corneal Limbal Stem Cell Transplant and Others) and major geographies with country level break-up.
Ajl Ophthalmic SA (Spain), Corneat Vision (Israel), CryoLife Inc. (United States), Exactech, Inc. (United States), Keramed Inc. (United States), Lifeline Scientific (United States), Medtronic plc. (United States), Organogenesis Inc. (United States), Presbia plc. (Ireland), Florida Lions Eye Bank (United States), San Diego Eye Bank (United States) and Massachusetts Eye and Ear (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Aurolab (India) and CorneaGen (United States).
Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Corneal Transplant market throughout the predicted period.
Segment Analysis
Analyst at AMA have segmented the market study of Global Corneal Transplant market by Type, Application and Region.
On the basis of geography, the market of Corneal Transplant has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Market Drivers
- Growing Geriatric Population Susceptible to Eye Diseases
- Growing Awareness Regarding Eye Disease Diagnosis
- Advantages Associated With Minimally Invasive Treatment Coupled With Growing Awareness Regarding Corneal Transplants That Provide Aesthetic Benefits
Market Trend
- Investment in R&D Activities for Innovation & Scope of Improvement
Restraints
- High Cost Associated With Cornea Implant Surgeries
Opportunities
- Advancement in Technologies and Developing Healthcare Infrastructure
- Presence of Skilled Healthcare Professionals
Challenges
- Patient Preference for Effective Treatment
The CMGs are guidelines on the diagnosis and management of a range of common and rare, but important, eye conditions that present with varying frequency in primary and first contact care.
Key Target Audience
Eye Hospital, Medical Surgery Center, Medical Research Laboratories, R&D Companies, Market Research and Consulting Service Providers and Others